Clinical Trials Logo

Precancerous Condition clinical trials

View clinical trials related to Precancerous Condition.

Filter by:

NCT ID: NCT01084083 Completed - Clinical trials for Head and Neck Cancer

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Start date: August 11, 2010
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as paclitaxel and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Radiation therapy uses high energy x-rays to kill tumor cells. Giving paclitaxel, cisplatin, and cetuximab together with radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying paclitaxel, cisplatin, and cetuximab to see how well they work when followed by cetuximab and two different doses of intensity-modulated radiation therapy in treating patients with HPV-associated stage III or stage IV cancer of the oropharynx that can be removed by surgery.

NCT ID: NCT01011478 Terminated - Colorectal Cancer Clinical Trials

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Start date: March 2010
Phase: Phase 3
Study type: Interventional

RATIONALE: Rosuvastatin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving rosuvastatin after surgery may kill any tumor cells that remain after surgery. It may also keep polyps from forming or colon cancer from coming back. It is not yet known whether rosuvastatin is more effective than a placebo in treating colon cancer that was removed by surgery. PURPOSE: This randomized phase III trial is studying rosuvastatin to see how well it works compared with placebo in treating patients with stage I or stage II colon cancer that was removed by surgery.

NCT ID: NCT00987857 Active, not recruiting - Esophageal Cancer Clinical Trials

Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus

Start date: March 2009
Phase: N/A
Study type: Interventional

RATIONALE: Screening tests may help doctors find cancer cells early and plan better treatment. It is not yet known whether endoscopy every 2 years is more effective than endoscopy only as needed in finding esophageal cancer in patients with Barrett esophagus. PURPOSE: This randomized phase III trial is studying endoscopy every 2 years to see how well it works compared with endoscopy only as needed in monitoring patients with Barrett esophagus.

NCT ID: NCT00978081 Completed - Clinical trials for Head and Neck Cancer

Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

Start date: January 2009
Phase: Phase 1
Study type: Interventional

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. PURPOSE: This randomized phase I trial is studying the side effects and best dose of photodynamic therapy in treating patients with premalignant or early stage head and neck tumors.

NCT ID: NCT00977392 Completed - Clinical trials for Precancerous Condition

Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening

Start date: June 2009
Phase: N/A
Study type: Observational

RATIONALE: Women who do not undergo routine cervical screening may be more likely to collect a self-sample for human papillomavirus testing. PURPOSE: This randomized clinical trial is studying self-sampling in women who do not undergo routine cervical screening.

NCT ID: NCT00955591 Completed - Anal Cancer Clinical Trials

Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men

Start date: March 12, 2009
Phase: N/A
Study type: Interventional

RATIONALE: Doctors use a swab to collect cell samples when testing for anal cancer and human papillomavirus. It is not yet known which type of swab is more effective in collecting cell samples for anal Pap tests and human papillomavirus tests in men who have sex with men. PURPOSE: This clinical trial is comparing two types of swabs in collecting cell samples for anal Pap tests and human papillomavirus tests in men who have sex with men.

NCT ID: NCT00942422 Terminated - Clinical trials for Multiple Myeloma and Plasma Cell Neoplasm

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Start date: November 2009
Phase: Phase 2
Study type: Interventional

RATIONALE: Green tea extract contains ingredients that may prevent or slow the growth of monoclonal gammopathy of undetermined significance and/or smoldering multiple myeloma. PURPOSE: This phase II trial is studying how well green tea extract works in treating patients with monoclonal gammopathy of undetermined significance and/or smoldering multiple myeloma.

NCT ID: NCT00919997 Completed - Clinical trials for Precancerous Condition

Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men

Start date: July 2009
Phase: N/A
Study type: Observational

RATIONALE: Gathering information about human papilloma virus (HPV) infection in HIV-positive men who have sex with men may help doctors learn more about the disease. PURPOSE: This clinical trial is studying HPV infection in HIV-positive Indian men who have sex with men.

NCT ID: NCT00918762 Completed - Clinical trials for Head and Neck Cancer

Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx

Start date: May 2009
Phase: Phase 1
Study type: Interventional

RATIONALE: Transoral robotic surgery may make it easier to find and remove benign or malignant tumors of the larynx and pharynx and cause less damage to normal tissue. It is not yet known whether transoral robotic surgery is more effective than standard surgery in diagnosing and treating larynx and pharynx tumors. PURPOSE: This phase I trial is studying how well transoral robotic surgery works compared with standard surgery in treating patients with benign or malignant tumors of the larynx or pharynx.

NCT ID: NCT00903136 Recruiting - Esophageal Cancer Clinical Trials

Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus

Start date: May 2009
Phase: Phase 1/Phase 2
Study type: Interventional

RATIONALE: A tethered capsule endoscope may be as effective as standard sedated endoscopy of the esophagus, stomach, and duodenum in screening for Barrett esophagus. PURPOSE: This phase I/II trial is studying how well a tethered capsule endoscope works in screening participants for Barrett esophagus.